MP
CORZ icon

Mangrove Partners’s Core Scientific CORZ Stock Holding History

Mangrove Partners’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$733K Sell
28,655
-14,806
-34% -$349K 0.05% 160
2026
Q1 		$650K Buy
+43,461
New +$741K 0.05% 153

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Mangrove Partners's CORZ Position: Q2 2026 in Review

Mangrove Partners reduced its Core Scientific (CORZ) stake by 34% in Q2 2026, selling an estimated $349K and leaving 28,655 shares worth $733K. The position accounts for 0.05% of the portfolio, ranked #160.

Mangrove Partners first reported a position in CORZ in Q1 2026 and has held it in 2 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Mangrove Partners held 28,655 shares of Core Scientific worth $733K as of Q2 2026.
  • Mangrove Partners sold 14,806 Core Scientific shares in Q2 2026, an estimated $349K.
  • Core Scientific made up 0.05% of Mangrove Partners's portfolio in Q2 2026, its #160 holding.
  • Mangrove Partners first reported a position in Core Scientific in Q1 2026 and has held it in 2 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.